Results 221 to 230 of about 68,051 (269)

Advances in Triboelectric Nanogenerators With Rotating Structure

open access: yesCarbon Energy, EarlyView.
The rotating TENG has been widely studied for its superiorities of simple structure, high efficiency, and stable output. This review introduced the four different principles of rotating TENG and offered a thorough summary for performance and application research through three‐level classification. Importantly, the current existing problems, challenges,
Chuguo Zhang   +4 more
wiley   +1 more source

Dissolution of mixed oxide(MOX) fuel in nitric acid:A review. [PDF]

open access: yesHeliyon
Li T   +5 more
europepmc   +1 more source

(NH4)2[Tc2O2(S2O7)4]: An Unexpected Technetium(V)‐Sulfate From the Reaction of (NH4)(TcO4) With SO3

open access: yesChemistry – A European Journal, EarlyView.
The reaction of the radioactive pertechnetate (99TcO4)− with the oxidizer SO3 leads to blue crystals of (NH4)2[Tc2O2(S2O7)4]. The complex dimeric [Tc2O2(S2O7)4]2− anion exhibits the technetium in the oxidation state V, showing that reduction occurs during the reaction.
Stefan Sutorius   +5 more
wiley   +1 more source

ESG Rating Disagreement and the Size of the Investable Universe Under ESG Consensus Rules

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT Using ESG scores of listed US companies from Refinitiv, ESG Book, MSCI, Moody's ESG, Bloomberg, and Sustainalytics for the period 2003–2022, we examine the extent of ESG rating disagreement and how it shapes the investable universe under ESG consensus rules.
Christian Lohmann   +2 more
wiley   +1 more source

Stimuli-responsive photoswitch-actinide binding: a match made in MOFs. [PDF]

open access: yesChem Sci
Park KC   +14 more
europepmc   +1 more source

Market Perceptions of ESG Reputational Risk in the US Pharmaceutical Industry

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT Negative ESG‐related reputational events generate significant corporate risks, particularly within sensitive sectors such as the pharmaceutical industry. Using novel reputational data, this research investigates investor perceptions of the consequences of experienced ESG breaches among US pharmaceutical firms.
Erdinc Akyildirim   +3 more
wiley   +1 more source

COMIP‐001: A clinical 13‐antibody, 12‐color flow cytometry panel for optimized immunophenotyping of T/NK cells in human leukemia and lymphoma diagnostics

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract The objective of this 12‐color/13‐antibody single‐tube panel is to assist in the diagnosis of T/NK‐cell leukemias and lymphomas. In the clinical setting, the absence of a standardized T/NK‐cell panel limits inter‐laboratory data comparability, contributes to diagnostic variability, and results in redundant efforts across laboratories to design
Nicole So   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy